Table 1. Demographics and HIV disease characteristics.
| 4–8 y of age | 9–17 y of age | 18–24 y of age | Total | |
|---|---|---|---|---|
| Total Number of Subjects | 24 | 23 | 26 | 73 |
| Gender | ||||
| Female | 14 (58%) | 10 (43%) | 14 (54%) | 38 (52%) |
| Race and Ethnicity | ||||
| Black | 14 (58%) | 14 (61%) | 15 (58%) | 43 (59%) |
| Latino | 13 (54%) | 10 (43%) | 7 (27%) | 30 (41%) |
| Age (yrs) | ||||
| Mean | 6 | 13 | 20 | 13 |
| Standard Deviation | 1.5 | 2 | 1.7 | 5.9 |
| CD4 Percent | ||||
| Mean | 38 | 34 | 29 | 34 |
| Standard Deviation | 6.9 | 6.4 | 10.2 | 8.7 |
| CD8 Percent | ||||
| Mean | 28 | 38 | 44 | 37 |
| Standard Deviation | 6.1 | 12.9 | 13 | 12.9 |
| Log 10 RNA Count | ||||
| Mean | 1.8 | 1.8 | 2.5 | 2.1 |
| Standard Deviation | 0.5 | 0.3 | 1.1 | 0.8 |
NOTES: The lower limit of detection varied among subjects depending on the assay used at the specific clinical research site; RNA values below the limit of detection were replaced with the lower limit of the assay (e.g., 18 cp/mL was replaced with 50 cp/mL for an assay with the limit of detection of 50 cp/mL).